
    
      Prospective observational study to evaluate the Quality of life based in patients treated
      with neoadjuvant or definitive chemoradiation for esophageal Cancer. QoL will be evaluated by
      standardized EORTC questionaires. Acute and late toxicity will be assessed according to CTCAE
      4.03. Outcome measures will include local Control, distant Control, freedom from Treatment
      failure and overall survival. Correlations are planned between Patient- and
      physician-assessed functional Outcome.
    
  